BLONDER TONGUE LABORATORIES INC (BDR) [Rocket]

Overview

BLONDER TONGUE LABORATORIES INC (BDR)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
05/02/2023	15-12G	Form 15-12G - Securities registration termination [Section 12(g)]:
04/28/2023	10-K/A	Annual Report for the period ended December 31, 2022 [amend]
04/17/2023	10-K	Annual Report for the period ended December 31, 2022
03/01/2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/13/2023	8-K	Quarterly results
01/23/2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/06/2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
Revenues	15.8	16.4	19.8	21.7	23.3	22.5	20.9	29.1
Revenue growth	-3.8%	-17.5%	-8.6%	-6.8%	3.5%	7.5%	-28.1%	4.5%
Cost of goods sold	9.9	13.4	16.4	13.3	14.3	14.1	16.8	18.2
Gross profit	5.9	3.0	3.4	8.4	8.9	8.4	4.2	11.0
Gross margin	37.2%	18.4%	17.3%	38.8%	38.4%	37.1%	19.8%	37.6%
Sales and marketing	2.5	2.5	3.0	2.5	2.5	2.5	3.1	3.4
Research and development	2.6	2.5	3.1	2.6	2.5	2.7	3.3	3.4
General and administrative	3.8	5.2	5.0	4.2	3.5	3.8	4.2	4.8
EBITA	-2.4	-6.3	0.2	0.1	1.0	0.0	-6.2	-0.4
EBITA margin	-15.3%	-38.3%	0.9%	0.3%	4.3%	0.1%	-29.7%	-1.3%
Amortization of intangibles	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.3
EBIT	-2.4	-6.3	0.0	-0.1	0.8	-0.1	-6.4	-0.6
EBIT margin	-15.3%	-38.3%	0.1%	-0.5%	3.5%	-0.6%	-30.6%	-2.2%
Pre-tax income	0.1	-7.5	-0.7	-1.4	-0.4	-1.2	-6.7	-0.9
Income taxes	0.0	0.0	0.0	-0.1	0.0	0.0	0.0	0.0
Tax rate	15.2%			5.4%	4.5%
Net income	0.1	-7.5	-0.7	-1.3	-0.4	-1.2	-6.8	-0.9
Net margin	0.5%	-45.6%	-3.7%	-6.2%	-1.6%	-5.3%	-32.3%	-3.1%

Diluted EPS	$0.01	($0.76)	($0.08)	($0.15)	($0.05)	($0.16)	($1.05)	($0.14)
Shares outstanding (diluted)	15.5	9.9	9.6	8.9	8.2	7.4	6.5	6.2

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.